Cite
MLA Citation
Benjamin A Teply et al.. “Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.” Lancet oncology, vol. 19, no. 1, 2018, pp. 76–86. http://access.bl.uk/ark:/81055/vdc_100055343178.0x00002f